Cargando…
Morusin exerts anti-cancer activity in renal cell carcinoma by disturbing MAPK signaling pathways
BACKGROUND: Renal cell carcinoma (RCC) has gradually become a severe type of kidney malignant tumor, which warrants an urgent need for highly efficacious therapeutic agents. Morusin, a typical prenylated flavonoid, has been revealed to possess anticarcinogenic effects against several cancers by inhi...
Autores principales: | Yang, Chengfei, Luo, Jing, Luo, Xing, Jia, Weisheng, Fang, Zhenqiang, Yi, Shanhong, Li, Longkun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186639/ https://www.ncbi.nlm.nih.gov/pubmed/32355771 http://dx.doi.org/10.21037/atm.2020.02.107 |
Ejemplares similares
-
DUSP9 Suppresses Proliferation and Migration of Clear Cell Renal Cell Carcinoma via the mTOR Pathway
por: Luo, Jing, et al.
Publicado: (2020) -
Association of Vitamin E Intake with Reduced Risk of Kidney Cancer: A Meta-Analysis of Observational Studies
por: Shen, Chongxing, et al.
Publicado: (2015) -
Exploring the therapeutic and anti-tumor properties of morusin: a review of recent advances
por: Hafeez, Amna, et al.
Publicado: (2023) -
Morusin Ameliorates IL-1β-Induced Chondrocyte Inflammation and Osteoarthritis via NF-κB Signal Pathway
por: Jia, Yewei, et al.
Publicado: (2020) -
Morusin alleviates mycoplasma pneumonia via the inhibition of Wnt/β-catenin and NF-κB signaling
por: Chen, Cunrong, et al.
Publicado: (2019)